(Q35259780)

7 August 2017

title

Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis. (English)

1 reference

7 August 2017

0 references

1 reference

Vic P

1

1 reference

7 August 2017

Ategbo S

2

1 reference

7 August 2017

Turck D

3

1 reference

7 August 2017

Husson MO

4

1 reference

7 August 2017

Launay V

5

1 reference

7 August 2017

Loeuille GA

6

1 reference

7 August 2017

Sardet A

7

1 reference

7 August 2017

Deschildre A

8

1 reference

7 August 2017

Druon D

9

1 reference

7 August 2017

Arrouet-Lagande C

10

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 June 1998

1 reference

Archives of Disease in Childhood

7 August 2017

published in

1 reference

7 August 2017

volume

78

1 reference

7 August 2017

issue

6

1 reference

7 August 2017

page(s)

536-539

1 reference

Optimisation of antibiotic therapy in cystic fibrosis patients. Pharmacokinetic considerations

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1717599

Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1717599

Management of acute pulmonary exacerbations in cystic fibrosis: a critical appraisal

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1717599

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1717599

Antibiotic therapy in cystic fibrosis: evaluation of clinical trials

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1717599

Strategies and perspectives in treatment of respiratory infections

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1717599

Endobronchial infection in cystic fibrosis.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1717599

Once-daily aminoglycoside administration: new strategies for an old drug

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1717599

Once-daily aminoglycoside therapy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1717599

Pharmacokinetic evaluation of single daily dose amikacin

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1717599

Influence of dosage schedule on renal cortical accumulation of amikacin and tobramycin in man

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1717599

Single daily dose therapy with aminoglycosides

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1717599

12 July 2018

1 reference

12 December 2020

Once daily dosing of aminoglycoside: one step forward

1 reference

12 December 2020

Home intravenous antibiotic treatment of patients with cystic fibrosis

1 reference

12 December 2020

Home care in cystic fibrosis patients

1 reference

12 December 2020

Pharmacokinetics of once-daily versus thrice daily tobramycin in cystic fibrosis patients

1 reference

12 December 2020

Tolerance, pharmacokinetics and efficacy of once daily amikacin for treatment of Pseudomonas aeruginosa pulmonary exacerbations in cystic fibrosis patients

1 reference

12 December 2020

Disposition of tobramycin in patients with cystic fibrosis: a prospective controlled study

1 reference

12 December 2020

Identifiers

DOI

10.1136/ADC.78.6.536

1 reference

7 August 2017

1 reference

7 August 2017

1 reference